Tus kws kho mob
P37-24 Residential Treatment Claims for Minnesota Health Care Programs
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 03, 2024
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1131 - 1140 ntawm 3685
Tus kws kho mob
Atypical Antipsychotics - Medicaid
Quantity Limit
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2025
Tus kws kho mob
Attention Deficit [Hyperactivity] Disorder (ADHD/ADD) Agents - Medicaid
Quantity Limit
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2025
Tus kws kho mob
Atypical Antipsychotics - Commercial
Step Therapy, Quantity Limit
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2025
Tus kws kho mob
gc-081-inappropriate-diagnosis-code-list.pdf
Tus kws kho mob
QP44-24 MHCP Pharmacy Benefit Exclusion for Anktiva® and Docivyx™
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 22, 2024
Tus kws kho mob
QP48-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2024
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2024
Tus kws kho mob
QP45-24 Commercial Pharmacy Benefit Exclusion for Jesduvroq, Tofidence™, and Tyenne®
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2024
Tus kws kho mob
QP47-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 15, 2024
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2024
Tus kws kho mob
QP96R1-23 EXL Health (EXL) to Perform Inpatient Facility Claim Reviews
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 26, 2024